Literature DB >> 2536702

Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.

F T Boyd1, J Massagué.   

Abstract

Cells whose proliferation is blocked by transforming growth factor-beta (TGF-beta) express three distinct surface glycoproteins of 53, 73, and 300 kDa that bind TGF-beta with high affinity, but whose function is unknown. We have isolated two classes of chemically-induced Mv1Lu epithelial cell mutants resistant to growth inhibition by TGF-beta. Class R mutants have selectively lost expression of the 53-kDa (type I) TGF-beta-binding protein. They have also lost the ability to respond to TGF-beta with elevated fibronectin expression and cell flattening. Class S mutants bind normally but do not respond to TGF-beta. TGF-beta-resistant mutants retain a contact inhibited, nontransformed phenotype. The properties of S mutants suggest that they are defective in the TGF-beta signal transduction mechanism, while the results with R mutants identify the type I TGF-beta-binding protein as the receptor involved in mediating TGF-beta actions on cell adhesion and proliferation.

Mesh:

Substances:

Year:  1989        PMID: 2536702

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

2.  Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity.

Authors:  S E Abraham; M C Carter; E Moran
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

3.  A variant of human growth differentiation factor-9 that improves oocyte developmental competence.

Authors:  William A Stocker; Kelly L Walton; Dulama Richani; Karen L Chan; Kiri H Beilby; Bethany J Finger; Mark P Green; Robert B Gilchrist; Craig A Harrison
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

4.  Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

Authors:  Elizabeth S Evans; Zafer Kocak; Su-Min Zhou; Daniel A Kahn; Hong Huang; Donna R Hollis; Kim L Light; Mitchell S Anscher; Lawrence B Marks
Journal:  Cytokine       Date:  2006-09-18       Impact factor: 3.861

Review 5.  Extracellular matrix molecules and their receptors: functions in neural development.

Authors:  L F Reichardt; K J Tomaselli
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

6.  Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.

Authors:  I Takanami; T Imamura; T Hashizume; K Kikuchi; Y Yamamoto; S Kodaira
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

7.  Oxidative exposure impairs TGF-β pathway via reduction of type II receptor and SMAD3 in human skin fibroblasts.

Authors:  Tianyuan He; Taihao Quan; Yuan Shao; John J Voorhees; Gary J Fisher
Journal:  Age (Dordr)       Date:  2014-02-20

8.  Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).

Authors:  K Hasegawa; Z Wang; M Inagaki; B I Carr
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

9.  Growth factor regulation of proliferation in primary cultures of small intestinal epithelium.

Authors:  C Booth; G S Evans; C S Potten
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

10.  Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.